AAAAAA

   
Results: 1-11 |
Results: 11
Performance of the analytical assays of paclitaxel, docetaxel, and cyclosporin a in a routine hospital laboratory setting
Authors: Malingre, MM Rosing, H Koopman, FJ Schellens, JHM Beijnen, JH
Citation: Mm. Malingre et al., Performance of the analytical assays of paclitaxel, docetaxel, and cyclosporin a in a routine hospital laboratory setting, J LIQ CHR R, 24(17), 2001, pp. 2697-2717
Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel
Authors: Terwogt, JMM Huinink, WWT Schellens, JHM Schot, M Mandjes, IAM Zurlo, MG Rocchetti, M Rosing, H Koopman, FJ Beijnen, JH
Citation: Jmm. Terwogt et al., Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel, ANTI-CANC D, 12(4), 2001, pp. 315-323
The effect of different doses of cyclosporin A on the systemic exposure oforally administered paclitaxel
Authors: Malingre, MM Beijnen, JH Rosing, H Koopman, FJ van Tellingen, O Duchin, K Huinink, WWT Swart, M Lieverst, J Schellens, JHM
Citation: Mm. Malingre et al., The effect of different doses of cyclosporin A on the systemic exposure oforally administered paclitaxel, ANTI-CANC D, 12(4), 2001, pp. 351-358
Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel
Authors: Malingre, MM Richel, DJ Beijnen, JH Rosing, H Koopman, FJ Huinink, WWTB Schot, ME Schellens, JHM
Citation: Mm. Malingre et al., Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel, J CL ONCOL, 19(4), 2001, pp. 1160-1166
A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A
Authors: Malingre, MM Beijnen, JH Rosing, H Koopman, FJ van Tellingen, O Duchin, K Huinink, WWT Swart, M Lieverst, J Schellens, JHM
Citation: Mm. Malingre et al., A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A, CANC CHEMOT, 47(4), 2001, pp. 347-354
Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients
Authors: Malingre, MM Beijnen, JH Rosing, H Koopman, FJ Jewell, RC Paul, EM Huinink, WWT Schellens, JHM
Citation: Mm. Malingre et al., Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients, BR J CANC, 84(1), 2001, pp. 42-47
High-performance liquid chromatographic methods for the determination of anovel polymer-bound paclitaxel derivative and free paclitaxel in human plasma
Authors: Terwogt, JMM Rosing, H Rocchetti, M Frigerio, E Fraier, D Koopman, FJ Schellens, JHM Huinink, WWT Beijnen, JH
Citation: Jmm. Terwogt et al., High-performance liquid chromatographic methods for the determination of anovel polymer-bound paclitaxel derivative and free paclitaxel in human plasma, J LIQ CHR R, 23(8), 2000, pp. 1233-1251
Metabolism and excretion of paclitaxel after oral administration in combination with cyclosporin A and after i.v. administration
Authors: Malingre, MM Schellens, JHM van Tellingen, O Rosing, H Koopman, FJ Duchin, K Huinink, WWT Swart, M Beijnen, JH
Citation: Mm. Malingre et al., Metabolism and excretion of paclitaxel after oral administration in combination with cyclosporin A and after i.v. administration, ANTI-CANC D, 11(10), 2000, pp. 813-820
Phase I and pharmacokinetic study of oral paclitaxel
Authors: Malingre, MM Terwogt, JMM Beijnen, JH Rosing, H Koopman, FJ van Tellingen, O Duchin, K Huinink, WWT Swart, M Lieverst, J Schellens, JHM
Citation: Mm. Malingre et al., Phase I and pharmacokinetic study of oral paclitaxel, J CL ONCOL, 18(12), 2000, pp. 2468-2475
Coadministration of oral cyclosporin a enables oral therapy with paclitaxel
Authors: Terwogt, JMM Malingre, MM Beijnen, JH Huinink, WWT Rosing, H Koopman, FJ van Tellingen, O Swart, M Schellens, JHM
Citation: Jmm. Terwogt et al., Coadministration of oral cyclosporin a enables oral therapy with paclitaxel, CLIN CANC R, 5(11), 1999, pp. 3379-3384
Pharmacokinetics of paclitaxel administered as a 3-hour or 96-hour infusion
Authors: Panday, VRN Huinink, WWT Vermorken, JB Rosing, H Koopman, FJ Swart, M Schellens, JHM Beijnen, JH
Citation: Vrn. Panday et al., Pharmacokinetics of paclitaxel administered as a 3-hour or 96-hour infusion, PHARMAC RES, 40(1), 1999, pp. 67-74
Risultati: 1-11 |